6505--Venlafaxine Tablets 36E79725R0054
Summary
AI-generated · Aug 24, 2025Venlafaxine HCL tablets are being procured for use by VA, DoD, BOP, and IHS under an unrestricted, single-source contract intended to ensure an uninterrupted supply. The contract will run for one year with four optional one-year extensions, and items will be distributed through the VA Pharmaceutical Prime Vendor Programs. Bidders must provide the exact label name and a unique NDC/UPC for each dosage form, and the requirement will be issued as a commercial item procurement. The anticipated RFP (36E79725R0050) will be released electronically around Sept 2, 2025, with a tentative closing date of Sept 16, 2025. Five dosages are required: 25 mg, 37.5 mg, 50 mg, 75 mg, and 100 mg, each in 90-count bottles, with estimated annual usage of 16,249 bottles for 100 mg, 5,854 for 25 mg, 13,163 for 37.5 mg, 4,259 for 50 mg, and 52,995 for 75 mg.
In the follow-up notice, the Awards section lists two awards but provides no award dates or amounts, indicating no concrete award information is available yet.
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79725R0050 for an unrestrictive procurement for Venlafaxine HCL Tablets for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC/UPC number. Solicitation #36E79725R0054 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 02, 2025, with a tentative closing date of September 16, 2025. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: www.beta.sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Michael Olszewski. Questions can be e-mailed to: Michael.Olszewski@va.gov. The estimated annual requirements are as follows: ITEM DESCRIPTION PACKAGE SIZE (Tablets per Bottle) TOTAL ESTIMATED ANNUAL USAGE (Bottles) 1 VENLAFAXINE HCL 100MG TAB 90 16,249 2 VENLAFAXINE HCL 25MG TAB 90 5,854 3 VENLAFAXINE HCL 37.5MG TAB 90 13,163 4 VENLAFAXINE HCL 50MG TAB 90 4,259 5 VENLAFAXINE HCL 75MG TAB 90 52,995
From Presolicitation posted on Aug 01, 2025N/A
From Solicitation posted on Aug 12, 2025Notice history
3-
Presolicitation Posted Aug 01, 2025
-
Solicitation Posted Aug 12, 2025View changes (4)
- Description: Description was updated
- Notice Type: Presolicitation → Solicitation
- Response Deadline: Sep 16, 2025 → Aug 26, 2025
- Set-Aside: None → None
-
Award Notice LATEST Posted Jan 16, 2026
Details
Award Information
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| GOLDEN STATE MEDICAL SUPPLY, INC. | GQLDJJ8AQNN5 | 1HT23 | CAMARILLO |
Contacts
Michael Olszewski
Phone